one of the first antidepressants to reach the UK market that was less dangerous than the tricyclic antidepressants in overdose; as of 2012 it was not prescribed much in the UK. Society and culture Generic names Mianserin is the English and German generic name of the drug and its and , while mianserin hydrochloride is its , , and . Its generic name in French and its are miansérine, in Spanish and Italian and its are mianserina, and in Latin is mianserinum. Brand names Mianserin is marketed in many countries mainly under the brand name Tolvon. It is also available throughout the world under a variety of other brand names including Athymil, Bonserin, Bolvidon, Deprevon, Lantanon, Lerivon, Lumin, Miansan, Serelan, Tetramide, and Tolvin among others. Availability Mianserin is not approved for use in the United States, but is available in the United Kingdom and other European countries. A mianserin generic drug received approval in May 1996 and is available in Australia. Research The use of mianserin to help people with schizophrenia who are being treated with antipsychotics has been studied in clinical trials; the outcome is unclear. References Further reading 5-HT1F antagonists Alpha-1 blockers Alpha-2 blockers H1 receptor antagonists Kappa-opioid receptor agonists Schering-Plough brands Merck & Co. brands Noradrenergic and specific serotonergic antidepressants Norepinephrine reuptake inhibitors Phenylpiperazines Serotonin receptor antagonists Tertiary amines Tetracyclic antidepressants